These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 35791076)

  • 1. Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction.
    Yu S; Sun Y; Shao X; Zhou Y; Yu Y; Kuai X; Zhou C
    J Microbiol Biotechnol; 2022 Jul; 32(7):825-834. PubMed ID: 35791076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiota in Inflammatory Bowel Disease.
    Qiu P; Ishimoto T; Fu L; Zhang J; Zhang Z; Liu Y
    Front Cell Infect Microbiol; 2022; 12():733992. PubMed ID: 35273921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease.
    He P; Yu L; Tian F; Zhang H; Chen W; Zhai Q
    Adv Nutr; 2022 Oct; 13(5):1628-1651. PubMed ID: 35348593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review.
    Di Vincenzo F; Del Gaudio A; Petito V; Lopetuso LR; Scaldaferri F
    Intern Emerg Med; 2024 Mar; 19(2):275-293. PubMed ID: 37505311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides and the gut microbiome in inflammatory bowel disease.
    Gubatan J; Holman DR; Puntasecca CJ; Polevoi D; Rubin SJ; Rogalla S
    World J Gastroenterol; 2021 Nov; 27(43):7402-7422. PubMed ID: 34887639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
    Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential effects of nutrition-induced alteration of gut microbiota on inflammatory bowel disease: A review.
    Tian QB; Chen SJ; Xiao LJ; Xie JQ; Zhao HB; Zhang X
    J Dig Dis; 2024 Feb; 25(2):78-90. PubMed ID: 38450936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal anesthesia alleviates dextran sodium sulfate-induced colitis by modulating the gut microbiota.
    Hong Y; Zhao J; Chen YR; Huang ZH; Hou LD; Shen B; Xin Y
    World J Gastroenterol; 2022 Mar; 28(12):1239-1256. PubMed ID: 35431512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.
    Fernández-Tomé S; Ortega Moreno L; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and inflammatory bowel disease.
    Chen L; Wang J
    WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.